Simvastatin induces impairment in skeletal muscle while heart is protected
Abstract
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) are widely used to reduce plasma cholesterol concentration. However, statins are also known to induce various forms of muscular toxicity. We have previously shown that acute application of simvastatin on human skeletal muscle samples induced a cascade of cellular events originating from mitochondria and resulting in a global alteration of Ca2+ homeostasis. The present study was designed to further define the origin of the mitochondria impairment and to understand the apparent lack of deleterious effect on the heart. Using fluorescence imaging analysis and oxygraphy on human and rat skinned skeletal muscle samples, we show that the simvastatin-induced mitochondria impairment results from inhibition of the complex I of respiratory chain. Similar simvastatin-induced mitochondria impairment and alteration of Ca2+ homeostasis occur in permeabilized but not in intact ventricular rat cardiomyocytes. In intact rat skeletal muscle fibers from the flexor digitorum brevis muscle, the simvastatin-induced alteration of Ca2+ homeostasis is abolished when monocarboxylate transporter (MCT4) is inhibited. The impairment of complex I by simvastatin might be the primary step of its cellular deleterious effects leading to muscle fiber death. This mechanism is seen specifically in skeletal muscles. This specificity should be in part attributed to a preferential uptake of statins by MCT4 that is not expressed in cardiomyocytes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Acute statin treatment was reported to lower complex I-linked OXPHOS capacity in human skeletal muscle without affecting complex II-linked respiration.
“The acute effect of statin treatment on mitochondrial oxidative phosphorylation (OXPHOS) capacity in human skeletal muscle has been investigated, and a decrease in OXPHOS capacity with complex I-linked substrates was reported, whereas respiration with complex II-linked substrates was unaffected (16).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [16]
Acute statin effects have been studied in isolated mitochondria from L6 cells and skinned human and rat muscle, where simvastatin showed a toxic effect and depressed complex I respiration.
“The acute effect of statins has, however, been studied in isolated mitochondria from L6 cells (a rat skeletal muscle cell line) (39) and in skinned human and rat muscle (16) in which a toxic effect of simvastatin and depressed complex I respiration was found.”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [16]
Statins decrease mitochondrial membrane potential in a dose-dependent manner.
“Third, it has previously been reported that statins, in a dose-dependent manner, decrease the mitochondrial membrane potential (16,39).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [16]
Cites
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · see citing works
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261 · see citing works
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/bj3430281 · Cited by 1,346 · see citing works
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,217 · see citing works
Beneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955 · see citing works
Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578 · see citing works
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M. F., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 485 · see citing works
Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo
Saks, V. A., Veksler, V., Kuznetsov, A. V., Kay, L., Sikk, P., Tiivel, T., Tranqui, L., Olivares, J., Winkler, K., Wiedemann, F. R., et al. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5653-4_7 · Cited by 361 · see citing works
Isoprenoids as mediators of the biological effects of statins
Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352 · see citing works
Fox, J. E. M., Meredith, D., & Halestrap, A. P. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00285.x · Cited by 331 · see citing works
Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vitro
Veksler, V., Kuznetsov, A. V., Kay, L., Sikk, P., Tiivel, T., Tranqui, L., Olivares, J., Winkler, K., Wiedemann, F. R., & Kunz, W. S. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006834912257 · Cited by 308 · see citing works
Cell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J., & Darżynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 296 · see citing works
HMG-CoA Reductase Inhibitors and Myotoxicity
Ucar, M., Mjörndal, T., & Dahlqvist, R. (2000) · Drug Safety · doi:10.2165/00002018-200022060-00003 · Cited by 279 · see citing works
Vaughan, C. J., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000139312.10076.ba · Cited by 218 · see citing works
Tobert, J. A., Bell, G. D., Birtwell, J., James, I. M., Kukovetz, W. R., Pryor, J., Buntinx, A., Holmes, I. B., Chao, Y. S., & Bolognese, J. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110530 · Cited by 204 · see citing works
Halcox, J., & Deanfield, J. E. (2004) · Circulation · doi:10.1161/01.cir.0000129500.29229.92 · Cited by 200 · see citing works
Ca2+ sparks and Ca2+ waves in saponin‐permeabilized rat ventricular myocytes
Lukyanenko, V. I., & Györke, S. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.00575.x · Cited by 166 · see citing works
Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle
Sirvent, P., Mercier, J., Vassort, G., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.070 · Cited by 154 · see citing works
Self-citationLactate transporters (MCT proteins) in heart and skeletal muscles
Bonen, A. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200004000-00010 · Cited by 150 · see citing works
Thomas, C., Sirvent, P., Perrey, S., de Mauverger, É. R., & Mercier, J. G. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00387.2004 · Cited by 142 · see citing works
Self-citationInteractions with hydroxymethylglutaryl-coenzyme A reductase inhibitors
Garnett, W. R. (1995) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/52.15.1639 · Cited by 125 · see citing works
Sacher, J., Weigl, L. G., Werner, M., Szegedi, C., & HOHENEGGER, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086462 · Cited by 103 · see citing works
Takeda, M., Noshiro, R., Onozato, M. L., Tojo, A., Hasannejad, H., Huang, X.-L., Narikawa, S., & Endou, H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.017 · Cited by 89 · see citing works
(1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90438-i · Cited by 65 · see citing works
Letellier, T., Bédes, F., Malgat, M., Korzeniewski, B., Jouaville, L. S., & Morkūnienė, R. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006875517267 · Cited by 52 · see citing works
Rhabdomyolysis with Simvastatin Use
Berland, Y., Coponat, V., Durand, C., Baz, M., Laugier, R., & Musso, J. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000186289 · Cited by 47 · see citing works
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40 · see citing works
SR33805, a Ca2+ antagonist with length‐dependent Ca2+‐sensitizing properties in cardiac myocytes
Cazorla, O., Lacampagne, A., Fauconnier, J., & Vassort, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705221 · Cited by 33 · see citing works
Self-citationMonocarboxylate Transporter Mediates Uptake of Lovastatin Acid in Rat Cultured Mesangial Cells
Nagasawa, K., Nagai, K., Sumitani, Y., Moriya, Y., Muraki, Y., Takara, K., Ohnishi, N., Yokoyama, T., & Fujimoto, S. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10246 · Cited by 29 · see citing works
Hudman, D., Rainbow, R. D., Lawrence, C., & Standen, N. B. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2024 · Cited by 23 · see citing works
Ultrastructure of mouse striated muscle fibers following pravastatin administration.
Bergman, M., Salman, H., Djaldetti, M., Alexandrova, S., Punsky, I., & Bessler, H. (2003) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1027367022415 · Cited by 21 · see citing works
Calcium, Cell Membrane, and Excitation-Contraction Coupling
Lüllmann, H., & Ziegler, A. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198710001-00002 · Cited by 6 · see citing works
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Toxicity of statins on rat skeletal muscle mitochondria
Kaufmann, P., Török, M., Zahno, A., Waldhauser, K. M., Brecht, K., & Krähenbühl, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6235-z · Cited by 263 · see citing works
Bouitbir, J., Charles, A.-L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., Piquard, F., Geny, B., & Zoll, J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr224 · Cited by 256 · see citing works
Effects of statins on mitochondrial pathways
Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 259 · see citing works
Simvastatin Impairs Exercise Training Adaptations
Mikus, C. R., Boyle, L. J., Borengasser, S. J., Oberlin, D. J., Naples, S. P., Fletcher, J. A., Meers, G. M.-E., Ruebel, M. L., Laughlin, M. H., Dellsperger, K. C., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.074 · Cited by 244 · see citing works
Turner, R. M., & Pirmohamed, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010022 · Cited by 201 · see citing works
New insights into mechanisms of statin-associated myotoxicity
Sirvent, P., Mercier, J. G., & Lacampagne, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.010 · Cited by 190 · see citing works
Self-citationAnalysis of mitochondrial function using phosphorescent oxygen-sensitive probes
Will, Y., Hynes, J., Ogurtsov, V. I., & Papkovsky, D. B. (2006) · Nature Protocols · doi:10.1038/nprot.2006.351 · Cited by 173 · see citing works
Simvastatin Effects on Skeletal Muscle
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165 · see citing works
Diagnosis and treatment of mitochondrial myopathies
Pfeffer, G., & Chinnery, P. F. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.605389 · Cited by 163 · see citing works
Clinical implications of pharmacogenomics of statin treatment
Mangravite, L. M., Thorn, C. F., & Krauss, R. M. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500384 · Cited by 162 · see citing works
Medication‐induced mitochondrial damage and disease
Neustadt, J. O., & Pieczenik, S. R. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700075 · Cited by 158 · see citing works
Turki, A., Hayot, M., Carnac, G., Pillard, F., Passerieux, E., Bommart, S., de Mauverger, É. R., Hugon, G., Pincemail, J., Pietri, S., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.041 · Cited by 152 · see citing works
Self-citationKwak, H.-B., Thalacker-Mercer, A., Anderson, E. J., Lin, C.-T., Kane, D. A., Lee, N.-S., Cortright, R. N., Bamman, M. M., & Neufer, P. D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.449 · Cited by 114 · see citing works
Mechanisms and assessment of statin‐related muscular adverse effects
Moßhammer, D., Schaeffeler, E., Schwab, M. G., & Mörike, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12360 · Cited by 110 · see citing works
The SLC16 monocaboxylate transporter family
Meredith, D., & Christian, H. (2008) · Xenobiotica · doi:10.1080/00498250802010868 · Cited by 103 · see citing works
Strategies to reduce late-stage drug attrition due to mitochondrial toxicity
Dykens, J. A., Marroquin, L. D., & Will, Y. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.161 · Cited by 95 · see citing works
Statins, Muscle Disease and Mitochondria
Ramachandran, R., & Wierzbicki, A. S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6080075 · Cited by 91 · see citing works
Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins
Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., & Mercier, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.008 · Cited by 90 · see citing works
Self-citationBouitbir, J., Charles, A.-L., Rasseneur, L., Dufour, S., Piquard, F., Geny, B., & Zoll, J. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00107.2011 · Cited by 86 · see citing works
Muntean, D. M., Thompson, P. D., Catapano, A. L., Stasiolek, M., Fabis, J., Muntner, P., Serban, M.-C., & Banach, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.001 · Cited by 82 · see citing works
Bland, A. R., Payne, F. M., Ashton, J. C., Jamialahmadi, T., & Sahebkar, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105986 · Cited by 82 · see citing works
Hematological Manifestations of Primary Mitochondrial Disorders
Finsterer, J. (2007) · Acta Haematologica · doi:10.1159/000105676 · Cited by 81 · see citing works
A novel potassium channel in skeletal muscle mitochondria
Skalska, J., Piwońska, M., Wyroba, E., Surmacz, L., Wieczorek, R. M., Koszela-Piotrowska, I., Zielińska, J., Bednarczyk, P., Dołowy, K., Wilczynski, G. M., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.05.007 · Cited by 81 · see citing works
Molecular mechanisms of statin intolerance
Gluba-Brzózka, A., Franczyk, B., Toth, P. P., Rysz, J., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59938 · Cited by 73 · see citing works
Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology
Janssen, L., Allard, N. A. E., Saris, C. G. J., Keijer, J., Hopman, M. T. E., & Timmers, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00002.2019 · Cited by 67 · see citing works
Drug-Induced Mitochondrial Toxicity in the Geriatric Population: Challenges and Future Directions
Will, Y., Shields, J. E., & Wallace, K. B. (2019) · Biology · doi:10.3390/biology8020032 · Cited by 65 · see citing works
Statins and skeletal muscles toxicity: From clinical trials to everyday practice
Norata, G. D., Tibolla, G., & Catapano, A. L. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.012 · Cited by 64 · see citing works
Bonifacio, A., Mullen, P. J., Mityko, I. S., Navegantes, L. C. C., Bouitbir, J., & Krähenbühl, S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1378-4 · Cited by 61 · see citing works
Galtier, F., Mura, T., de Mauverger, É. R., Chevassus, H., Farret, A., Gagnol, J., Costa, F., Dupuy, A., Petit, P., Cristol, J., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.06.020 · Cited by 55 · see citing works
Self-citationPierno, S., Camerino, G. M., Cippone, V., Rolland, J., Desaphy, J., Luca, A. D., Liantonio, A., Bianco, G., Kunic, J., George, A. L., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00079.x · Cited by 52 · see citing works
Rosuvastatin: Characterization of Induced Myopathy in the Rat
Westwood, F. R., Scott, R. C., Marsden, A. M., Bigley, A. L., & Randall, K. (2008) · Toxicologic Pathology · doi:10.1177/0192623307311412 · Cited by 51 · see citing works
Mitochondria of trained skeletal muscle are protected from deleterious effects of statins
Bouitbir, J., Daussin, F., Charles, A., Rasseneur, L., Dufour, S. P., Richard, R., Piquard, F., Gény, B., & Zoll, J. (2012) · Muscle & Nerve · doi:10.1002/mus.23309 · Cited by 46 · see citing works
Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 46 · see citing works
Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies
Taha, D. A., de Moor, C. H., Barrett, D. A., & Gershkovich, P. (2014) · Translational research · doi:10.1016/j.trsl.2014.01.013 · Cited by 45 · see citing works
Bonfim, M. R., Oliveira, A. S. B., Amaral, S. L., & Monteiro, H. L. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150005 · Cited by 43 · see citing works
Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy
Schmitz, G., Schmitz-Mądry, A., & Ugocsai, P. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3280555083 · Cited by 44 · see citing works
Rossato, F. A., Zecchin, K. G., Guardia, P. G. L., Ortega, R. M., Alberici, L. C., Costa, R. A. P. E., Catharino, R. R., Graner, E., Castilho, R. F., & Vercesi, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101060 · Cited by 43 · see citing works
Protective Effects of Coenzyme Q10 on Decreased Oxidative Stress Resistance Induced by Simvastatin
Kettawan, A., Takahashi, T., Kongkachuichai, R., Charoenkiatkul, S., Kishi, T., & Okamoto, T. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.40.194 · Cited by 41 · see citing works
Melo‐Hanchuk, T. D., Slepicka, P. F., Guardia, P. G. L., Vercesi, A. E., & Kobarg, J. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.021 · Cited by 36 · see citing works
Goodman, C. A., Derk, P., Zacharewicz, E., Lee, R. S., Snow, R. J., Russell, A. P., & McConell, G. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128398 · Cited by 35 · see citing works
Busanello, E. N. B., Marques, A. C. S., Lander, N. M., de Oliveira, D. N., Catharino, R. R., Oliveira, H. C. F., & Vercesi, A. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00185 · Cited by 34 · see citing works
Abo-Zalam, H. B., El-Denshary, E. S., Abdelsalam, R. M., Khalil, I. A. H., Khattab, M. M., & Hamzawy, M. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111494 · Cited by 35 · see citing works
The role of acid-base imbalance in statin-induced myotoxicity
Taha, D. A., de Moor, C. H., Barrett, D. A., Lee, J. B., Gandhi, R. D., Hoo, C. W., & Gershkovich, P. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.015 · Cited by 35 · see citing works
Cardiopulmonary Exercise Testing and Metabolic Myopathies
Riley, M., Nicholls, D., & Cooper, C. B. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-014fr · Cited by 33 · see citing works
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 30 · see citing works
Barrat, E., Zaïr, Y., Sirvent, P., Chauveau, P., Maudet, C., Housez, B., Derbord, E., Lescuyer, J.-F., Bard, J.-M., Cazaubiel, M., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0486-2 · Cited by 31 · see citing works
Self-citationThe Effects of Statin Medications on Aerobic Exercise Capacity and Training Adaptations
Murlasits, Z., & Radak, Z. O. (2014) · Sports Medicine · doi:10.1007/s40279-014-0224-4 · Cited by 32 · see citing works
Shi, Z., & Han, S. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41629 · Cited by 34 · see citing works
Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation
Callegari, S., McKinnon, R. A., Andrews, S., & de Barros Lopes, M. A. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00593.x · Cited by 28 · see citing works
Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan
Miller, B. F., & Thyfault, J. P. (2020) · Physiology · doi:10.1152/physiol.00013.2020 · Cited by 29 · see citing works
Jaśkiewicz, A., Pająk, B., Litwiniuk, A., Urbańska, K., & Orzechowski, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6463807 · Cited by 28 · see citing works
Implication of Lipids in Calcified Aortic Valve Pathogenesis: Why Did Statins Fail?
Nsaibia, M. J., Devendran, A. S., Goubaa, E., Bouitbir, J., Capoulade, R., & Bouchareb, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123331 · Cited by 24 · see citing works
Riazi, S., Kraeva, N., Muldoon, S. M., Dowling, J. J., Ho, C., Petre, M.-A., Parness, J., Dirksen, R. T., & Rosenberg, H. R. (2014) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-014-0227-5 · Cited by 27 · see citing works
Mice with RyR1 mutation (Y524S) undergo hypermetabolic response to simvastatin
Knoblauch, M. A., Dagnino-Acosta, A., & Hamilton, S. L. (2013) · Skeletal Muscle · doi:10.1186/2044-5040-3-22 · Cited by 27 · see citing works
Obayashi, H., Nezu, Y., Yokota, H., Kiyosawa, N., Mori, K., Maeda, N., Tani, Y., Manabe, S., & Sanbuissho, A. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.445 · Cited by 26 · see citing works
RYAN, T. E., Torres, M. J., Lin, C., Clark, A. H., Brophy, P. M., Smith, C. A. S., Smith, C. D., Morris, E. M., Thyfault, J. P., & Neufer, P. D. (2024) · JCI Insight · doi:10.1172/jci.insight.174125 · Cited by 26 · see citing works
Trapani, L., Melli, L., Segatto, M., Trezza, V., Campolongo, P., Jozwiak, A., Swiezewska, E., Pucillo, L. P., Moreno, S., Fanelli, F., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-184218 · Cited by 25 · see citing works
Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability
Copaja, M., Venegas, D., Aránguiz, P., Canales, J., Vivar, R., Avalos, Y., Garcı́a, L., Chiong, M., Olmedo, I., Catalán, M., et al. (2012) · Toxicology · doi:10.1016/j.tox.2012.01.011 · Cited by 24 · see citing works
Simvastatin Inhibits L-Type Ca2+-Channel Activity Through Impairment of Mitochondrial Function
Curry, L., Almukhtar, H. M., Alahmed, J. A. S., Roberts, R. E., & Smith, P. A. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz068 · Cited by 23 · see citing works
Chung, J., Brass, E., Ulrich, R., & Hiatt, W. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100264 · Cited by 21 · see citing works
Venturi, E., Lindsay, C., Lotteau, S. J., Yang, Z., Steer, E., Witschas, K., Wilson, A. D., Wickens, J. R., Russell, A. J., Steele, D. S., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14136 · Cited by 20 · see citing works
The Role of Mitochondria in Statin-Induced Myopathy
Bell, G. M., Thoma, A., Hargreaves, I. P., & Lightfoot, A. P. (2024) · Drug Safety · doi:10.1007/s40264-024-01413-9 · Cited by 21 · see citing works
Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity
Kikutani, Y., Kobayashi, M., Konishi, T., Sasaki, S., Narumi, K., Furugen, A., Takahashi, N., & Iseki, K. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.014 · Cited by 19 · see citing works
Marques, A. C. S., Busanello, E. N. B., de Oliveira, D. N., Catharino, R. R., Oliveira, H. C. F., & Vercesi, A. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00685 · Cited by 18 · see citing works
Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth
Trotta, F., Avena, P., Chimento, A., Rago, V., Luca, A. D., Sculco, S., Nocito, M. C., Malivindi, R., Fallo, F., Pezzani, R., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1063 · Cited by 18 · see citing works
Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
Li, J., Liu, H.-H., Wu, N., Yeo, K. K., Tan, K. C. B., Ako, J., Krittayaphong, R., Tan, R., Aylward, P. E., Baek, S. H., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1802426 · Cited by 19 · see citing works
EXPRESSION OF CONCERN: Mitophagy protects against statin‐mediated skeletal muscle toxicity
Ramesh, I., Campos, J. C., Lee, P., Song, Y., Hernandez, G., Sin, J., Tucker, K. C., Saadaeijahromi, H., Gurney, M., Ferreira, J. C. B., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900807rr · Cited by 17 · see citing works
Statins interfere with the attachment of S. cerevisiae mtDNA to the inner mitochondrial membrane
Cirigliano, A., Amelina, A., Biferali, B., Macone, A., Mozzetta, C., Bianchi, M. M., Mori, M., Botta, B., Pick, E., Negri, R., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1687461 · Cited by 14 · see citing works
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 18 · see citing works
Singla, M., Rastogi, A., Aggarwal, A. N., Bhat, O. M., Badal, D., & Bhansali, A. K. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12541 · Cited by 17 · see citing works
Hepatocellular Carcinoma and Statins
Talesh, G. A., Trézéguet, V., & Merched, A. J. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00476 · Cited by 16 · see citing works
A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles
Boulanger‐Piette, A., Dufresne, S. S., & Frenette, J. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1306-2 · Cited by 15 · see citing works
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43938-5 · Cited by 15 · see citing works
Jaśkiewicz, A., Pająk, B., Łabieniec-Watała, M., Palma, C. D., & Orzechowski, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050694 · Cited by 13 · see citing works
Iwaki, Y., Lee, W., & Sugiyama, Y. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1681399 · Cited by 14 · see citing works
Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target
Xing, W., Li, X., Zhou, Y., Li, M., & Zhu, M. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00160 · Cited by 12 · see citing works
Christiansen, L. B., Dohlmann, T. L., Ludvigsen, T. P., Parfieniuk, E., Ciborowski, M., Szczerbiński, Ł., Kretowski, A. J., Desler, C., Tiano, L., Orlando, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81846-9 · Cited by 12 · see citing works
Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice
D’Antona, G., Mascaro, A., Monopoli, A., Miglietta, D., Ongini, E., & Bottinelli, R. (2012) · Muscle & Nerve · doi:10.1002/mus.23465 · Cited by 12 · see citing works
Molecular mechanisms of toxicity of simvastatin, widely used cholesterol-lowering drug. A review
Kaminsky, Y. G., & Kosenko, E. A. (2009) · Open Medicine · doi:10.2478/s11536-009-0123-5 · Cited by 12 · see citing works
Statins and Exercise Training Response in Heart Failure Patients
Kelly, J. P., Dunning, A. M., Schulte, P. J., Fiuzat, M., Leifer, E., Fleg, J. L., Cooper, L. S., Keteyian, S. J., Kitzman, D. W., Piña, I. L., et al. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.05.006 · Cited by 11 · see citing works
Statin-induced liver and muscle toxicities
Lee, W. S., & Kim, J. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-019-0002-3 · Cited by 10 · see citing works
Cardiac and skeletal muscle changes associated with rosuvastatin therapy in dystrophic mdx mice
Finkler, J. M. G., de Carvalho, S. C., Neto, H. S., & Marques, M. J. (2019) · The Anatomical Record · doi:10.1002/ar.24341 · Cited by 12 · see citing works
Buettner, C., Greenman, R. L., Ngo, L. H., & Wu, J. S. (2016) · PubMed · Cited by 11 · see citing works
Effects of HMG CoA reductase ( HMGCR ) deficiency on skeletal muscle development
Gunasekaran, M., Littel, H. R., Wells, N. M., Turner, J., Campos, G., Venigalla, S., Estrella, E. A., Ghosh, P. S., Daugherty, A. L., Stafki, S. A., et al. (2025) · FEBS Journal · doi:10.1111/febs.17406 · Cited by 11 · see citing works
Murad, H. A. S. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500065 · Cited by 6 · see citing works
Hamid, K. M. A., Mola, A. F. A., Meligy, F. Y., & Allah, E. S. H. A. (2017) · The Egyptian Journal of Histology · doi:10.21608/ejh.2017.4074 · Cited by 6 · see citing works
Obayashi, H., Kobayashi, N., Nezu, Y., Yamoto, T., Shirai, M., & Asai, F. (2017) · The Journal of Toxicological Sciences · doi:10.2131/jts.42.385 · Cited by 6 · see citing works
Callegari, S., Gregory, P. A., Sykes, M. J., Bellon, J., Andrews, S., McKinnon, R. A., & Lopes, M. D. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002755 · Cited by 6 · see citing works
Somers, T., Siddiqi, S., Janssen, M. C. M., Morshuis, W. J., Maas, R. G. C., Buikema, J. W., van den Broek, P. H. H., Schirris, T. J. J., & Rüssel, F. G. M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117492 · Cited by 5 · see citing works
Successful treatment of a patient with mitochondrial myopathy with alirocumab
Cicero, A. F. G., Fogacci, F., Bove, M., & Borghi, C. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.07.007 · Cited by 4 · see citing works
Halvey, P. J., Hansen, J. M., Lash, L. H., & Jones, D. P. (2008) · doi:10.1002/9780470372531.ch18 · Cited by 4 · see citing works
Statin and Fibrate‐Induced Dichotomy of Mitochondrial Function
Neergheen, V., Dyson, A., Wainwright, L., & Hargreaves, I. P. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch30 · Cited by 4 · see citing works
Role of Monocarboxylate Transporter in Statin-induced Cytotoxicity
Kobayashi, M. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.15-00199 · Cited by 3 · see citing works
The Role of the Mitochondria in SAMS
Allard, N. A. E., & Timmers, S. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_12 · Cited by 2 · see citing works
Transport of statins by multidrug resistance-associated proteins 1 and 5
Tuomi, S.-K., Deng, F. Y., Neuvonen, M., & Niemi, M. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107070 · Cited by 2 · see citing works
Guis, S., Bendahan, D., & Mattei, J. (2007) · Revue du Rhumatisme · doi:10.1016/j.rhum.2007.08.005 · Cited by 2 · see citing works
Blood cholesterol and mitochondrial toxicity of simvastatin
Kaminsky, Y. G., & Kosenko, E. A. (2011) · Biology Bulletin Reviews · doi:10.1134/s2079086411040013 · Cited by 2 · see citing works
Sorrentino, M. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00029-4 · Cited by 2 · see citing works
Obayashi, H., Kobayashi, N., Nezu, Y., Yamoto, T., Shirai, M., & Asai, F. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.601 · Cited by 2 · see citing works
Effects of HMGCR deficiency on skeletal muscle developmentPreprint
Gunasekaran, M., Littel, H. R., Wells, N. M., Turner, J., Campos, G., Venigalla, S., Estrella, E. A., Ghosh, P. S., Daugherty, A. L., Stafki, S. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.06.591934 · Cited by 2 · see citing works
- Authors
- Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Raynaud, E., & Lacampagne, A.
- Affiliations
- Inserm (FR)
- Université Montpellier 1 (FR)
- Corresponding author
- Lacampagne, Alain
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 338
- Issue
- 3
- Pages
- 1426-1434
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2089611661
- Cited by
- 116
- References
- 34
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 10 · 2015: 6 · 2014: 8 · 2013: 3 · 2012: 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Agence Française de Sécurité Sanitaire des Produits de Santé
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- simvastatin, statin-induced myopathy, skeletal muscle, mitochondrial complex I inhibition, calcium homeostasis, MCT4, cardiomyocytes, statins, mitochondrial permeability transition
- MeSH terms
- Animals, Calcium, Cell Membrane, Cytosol, Electron Transport, Heart, Homeostasis, Humans, Male, Mitochondria, Heart, Myocardium, Rats, Wistar, Muscle, Skeletal, Simvastatin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review